Enobia Pharma - Ownership and Business Overview

Healthcare ServicesCompany

Enobia Pharma Ownership

Who owns Enobia Pharma?

Enobia Pharma is owned by Alexion Pharmaceuticals. It was acquired on December 28, 2011.

Enobia Pharma Business Overview

Where is Enobia Pharma headquartered?

Enobia Pharma is headquartered in Montreal, Quebec.

What sector is Enobia Pharma in?

Enobia Pharma is a healthcare services company.

Healthcare Services M&A Summary in 2011

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2011. The largest healthcare services acquisition in 2011 was HealthSpring - which was acquired by The Cigna Group for $3.8B.

Join Mergr to view all 302 acquisitions of healthcare services companies in 2011, including 67 acquisitions by private equity firms, and 235 by strategics.

Enobia Pharma

Enobia Pharma Corp.

2901, Rachel Street East, #23,
Montreal, Quebec H1W 4A4
Canada,
www.enobia.com

Enobia Pharma focuses on the development of therapies for patients with genetic metabolic bone disorders. Enobia's lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. Enobia is based in Montreal, Quebec.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.